TTP silencing, likely by preventing the downregulation of specific TTP targets, including MYC, IER3, and AKT1, has been reported to equally restrain apoptosis induced by a MAPK inhibitor (PHA-781089) in hepatic cancer cell lines [141]. Here, ZFP36 is linked to liver cancer.